ArticleCancers2022

An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia.

Abel Tesfaye Anshabo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.